Anticoagulation Control in Sweden: Reports of Time in Therapeutic Range, Major Bleeding, and Thrombo-Embolic Complications From the National Quality Registry AuriculA

Study Questions:

What are the patient characteristics, time in therapeutic range (TTR), bleeding, and thromboembolic complications in the Swedish national quality registry for atrial fibrillation and anticoagulation?